1 / 20

Chronic Thromboembolic Pulmonary Hypertension

Chronic Thromboembolic Pulmonary Hypertension. AM Report Lauren Galpin , MD MA. Definitions. “ Thromboembolic obstruction of the major pulmonary arteries due to unresolved pulmonary embolism [with pulmonary hypertension]”

aphrodite-griffin
Télécharger la présentation

Chronic Thromboembolic Pulmonary Hypertension

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Chronic Thromboembolic Pulmonary Hypertension AM Report Lauren Galpin, MD MA

  2. Definitions “Thromboembolic obstruction of the major pulmonary arteries due to unresolved pulmonary embolism [with pulmonary hypertension]” “intraluminal thrombus organization and fibrous stenosis or complete obliteration of pulmonary arteries… The consequence is an increased pulmonary vascular resistance resulting in pulmonary hypertension and progressive right heart failure.”

  3. Epidemiology • True incidence unknown • 500-2500 pts per year, 0.1-0.5% acute PE survivors • 2 prospective follow up studies of patients with acute PE: • 44% had persistent pulmonary htn +/- RV dysfunction, 5.1% developed CTEPH • 3.1% had CTEPH at 1 year, 3.8% at 2 years • Up to 2/3 of patients with CTEPH have no history of acute PE

  4. Epidemiology • Risk factors: • 223 patient study: • Previous PE history • large perfusion deficit • younger age • 78 patient study: • Age>70 • systolic pulmonary artery pressure >50mmHg at time of diagnosis • Echo at 6 weeks accurately distinguished complete resolution from persistent pulmonary htn.

  5. Pathophysiology • Recurrent thromboembolism • In situ pulmonary artery thrombosis • From underlying arteriopathy? • Pulmonary vascular remodeling • Genetic susceptibility? • Inflammatory mechanism?

  6. Pulmonary Vascular Remodeling Low correlation between degree of obstruction and degree of pulmonary hypertension Hemodynamic progression is seen in absence of recurrent events Histopathologic evidence

  7. Pulmonary Vascular Remodeling • “Two compartment pulmonary vasculature bed” – Braunwald and Moser, 1971 • Non-obstructed arteries showed changes consistent with chronic pumonary hypertension • Arteries distal to occlusion were normal

  8. Associated conditions/risks • 10-20% have anticardiolipin antibody • Elevated factor VIII • Chronic inflammatory disorders • Myeloproliferative disorders • Venticulo-atrial shunt • Splenectomy • Abnormal RBCs interaction with pulmonary arteries? • Abnormal RBCs act as prothrombotic? • Abnormal platelet activation?

  9. Clinical Manifestations • May be asymptomatic months – years • Physical exam findings • Accentuated pulmonic component S2 • Bruits over anterior lung fields • Dyspnea/exercise intolerance, chest pain, presyncope, syncope  late

  10. Diagnosis LE Doppler V/Q scan CT angiogram Right heart catheterization Angioscopy MRA with contrast

  11. Differential Diagnosis • Of segmental perfusion deficits on V/Q scan • Pulmonary veno-occlusive disease • Pulmonary capillary hemangiomatosis • Fibrosingmediastinitis • Pulmonary vasculitis • Sarcomas of pulmonary arteries

  12. Prognosis • Without treatment • Pulmonary Arterial Pressure >40mmHg: 30% 5y survival • PAP>50mmHg: 10% 5y survival • In another study, >30mmHg: 10% survival

  13. Prognosis • With Pulmonary Endarterectomy (+lifelong anticoagulation and IVC filter) • 5-24% perioperative mortality overall, <5% at experienced centers • In experienced centers, well-selected patients • Near normalization of hemodynamics • Substantial improvement in clinical symptoms

  14. “… there is no degree of embolic occlusion within the pulmonary vascular tree that is inaccessible and no degree of right ventricular impairment or any level of pulmonary vascular resistance that is inoperable.” -- Jamieson et al, UCSD

  15. Other treatment options • Medicine • Epoprostenol – prostacyclin infusion • Sildenafil – phosphodiesterase-5 inhibitor • Bosentan – endothelin receptor antagonist • Balloon angioplasty • Has been done successfully • Still considered experimental • Lung transplant • For people with advanced small vessel disease without comorbidities that preclude surgery

  16. Take Home Points Review of systems and careful physical exam are important! Chronic thromboembolic disease is uncommon, but not rare Chronic thromboembolism is a treatable cause of pulmonary hypertension V/Q scan still an important diagnostic tool “No 21 year-old should ever be short of breath.”

More Related